Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis

As indicators of responsiveness to a tumour necrosis factor (TNF)α blocking agent (infliximab) are lacking in rheumatoid arthritis, we have used gene profiling in peripheral blood mononuclear cells to predict a good versus poor response to infliximab. Thirty three patients with very active disease (...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Lequerré, Thierry, Gauthier-Jauneau, Anne-Christine, Bansard, Carine, Derambure, Céline, Hiron, Martine, Vittecoq, Olivier, Daveau, Maryvonne, Mejjad, Othmane, Daragon, Alain, Tron, François, Le Loët, Xavier, Salier, Jean-Philippe
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2006
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC1779405/
https://ncbi.nlm.nih.gov/pubmed/16817978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar1990
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia